Mads Hald Andersen

44PUBLICATIONS
148CO-AUTHORS
Tissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jun 23, 2026
Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cells.

|Apr 10, 2026
Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond.

Mads Hald Andersen

|Apr 08, 2026
Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation.

Morten Orebo Holmström, Lia Minculescu, Katrine Nørgaard

|Mar 24, 2026
Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates.

Josephine Hallundbæk Ruders, Shamaila Munir Ahmad, Rasmus Erik Johansson Mortensen

|Dec 14, 2025
Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma.

Sidsel Pedersen, Mikkel Byrdal, Evelina Martinenaite

|Nov 17, 2025
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.

Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder

Pageof 8

Frequent Collaborators

9 joint publications

Morten Orebo Holmström

9 joint publications

Inge Marie Svane

7 joint publications

Maria Perez-Penco

5 joint publications

Özcan Met